Owens & Minor, Inc. OMI was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 46.5% in the past one-month time frame.The company has seen two positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Owens & Minor. So, make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.Owens & Minor currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.Owens Minor, Inc. Price Owens Minor, Inc. price | Owens Minor, Inc. QuoteAnother stock worth considering in the Medical - Products industry is Meridian Bioscience, Inc. VIVO which carries a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.Breakout Biotech Stocks with Triple-Digit Profit PotentialThe biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Owens Minor, Inc. (OMI): Free Stock Analysis Report Meridian Bioscience Inc. (VIVO): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research